Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.65 HKD | -2.77% | +6.92% | -9.59% |
17/04 | Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer | CI |
02/04 | Hutchmed endometrial cancer treatment application accepted for review | AN |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.
- Press Releases